公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Activation of Checkpoint Kinase 2 (Chk2) Contributes to the Antitumour Synergy between Igf1 Receptor Kinase Inhibitor Nvp-Aew541 and Sunitinib in Hepatocellular Carcinoma | OU, DA-LIANG; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII | EUROPEAN JOURNAL OF CANCER | | | |
2011 | Phase Ii Study of Low-Dose Everolimus Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for First-Line Treatment of Metastatic or Recurrent Gastric Cancers | YEH, KUN-HUEI; SHEN, YING-CHUN; LIN, YU-LIN; LIN, ZONG-ZHE; CHEN, LI-TZONG; CHAO, YEE; CHENG, ANN-LII | EUROPEAN JOURNAL OF CANCER | | | |
2010 | Potentiating the Anti-Tumor Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Signaling Pathway | OU, DA-LIANG; HSU, CHIUN; SHEN, YING-CHUN; CHENG, ANN-LII | EJC SUPPLEMENTS | | | |
2011 | Signal transducer and activator of transcription 3 is a major kinase- independent target of sorafenib in hepatocellular carcinoma=STAT3為 Sorafenib於肝癌的主要標的 | TAI, WEI-TIEN; CHENG, ANN-LII; SHIAU, CHUNG-WAI; HUANG, HSIANG-PO; HUANG, JUI-WEN; CHEN, PEI-JER; CHEN, KUEN-FENG; 鄭安理; 陳培哲 | Journal of Hepatology | | | |